Case Report: IVIG Treatment for Recurrent COVID-19 in a B-Cell Depleted Patient

A figshare-hosted medical case report details the successful treatment of a 47-year-old woman with prolonged COVID-19 pneumonia following rituximab therapy. Authored by Hee Bum Jo and last updated in May 2026, the document describes the use of intravenous immunoglobulin (IVIG) and includes longitudinal serologic analyses of antibody titers and Fc-mediated effector functions. The dataset is a single document file under a CC-BY-4.0 license.

Use Cases

• Analyze the clinical course of COVID-19 based on the description of serial hospital admissions and treatment responses
• Study the restoration of immune effector functions based on the longitudinal serologic analyses of ADCC and ADCP activities
• Investigate salvage therapy mechanisms based on the reported changes in SARS-CoV-2-specific IgG titers before and after IVIG infusion

Strengths

• Includes detailed longitudinal serologic data on antibody titers and Fc-mediated functions
• Provides a complete clinical narrative with specific treatments and outcomes
• Released under a permissive CC-BY-4.0 license

Limitations

• Description metadata is limited; actual data quality requires manual inspection after download
• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download

Provenance

Source

figshare

Collection Method

Clinical case report and associated laboratory analysis.

Freshness

Last updated 2026-05-25 06:05:24; freshness should be verified